(4R)-4-Methyl-1,3,2-dioxathiolane-2,2-dioxide - CAS 1006381-03-8
Catalog: |
BB056472 |
Product Name: |
(4R)-4-Methyl-1,3,2-dioxathiolane-2,2-dioxide |
CAS: |
1006381-03-8 |
Synonyms: |
1,3,2-Dioxathiolane, 4-methyl-, 2,2-dioxide, (4R)-; (R)-4-Methyl-1,3,2-dioxathiolane 2,2-dioxide; (4R)-4-Methyl-1,3,2-dioxathiolane 2,2-dioxide; (4R)-4-Methyl-1,3,2-dioxathiolane-2,2-dioxide; (4R)-Methyl-[1,3,2]dioxathiolane 2,2-dioxide |
IUPAC Name: | (4R)-4-methyl-1,3,2-dioxathiolane 2,2-dioxide |
Description: | (4R)-4-Methyl-1,3,2-dioxathiolane-2,2-dioxide, can be used in the synthesis of stereoisomers of Secnidazole (S225000), which is a nitroimidazole anti-infective, that is shown to be effective in treatment of dientamoebiasis, and Atopobium vaginae. |
Molecular Weight: | 138.14 |
Molecular Formula: | C3H6O4S |
Canonical SMILES: | CC1COS(=O)(=O)O1 |
InChI: | InChI=1S/C3H6O4S/c1-3-2-6-8(4,5)7-3/h3H,2H2,1H3/t3-/m1/s1 |
InChI Key: | OQXNUCOGMMHHNA-GSVOUGTGSA-N |
References: | De Backer, E. et al. Clinc. Micro. Infec., 16, 470 (2009); Cosar, C., et al. Arzneim.-Forsch., 16, 23 (1966); Videau, D., et al. Br. J. Vener. Dis., 54, 77 (1978); Symonds, J., et al. J. Antimicrob. Chemother., 5, 484 (1979). |
GHS Hazard Statement: | H302 (50%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P203, P264, P270, P281, P301+P317, P318, P330, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2022017338-A1 | Tetrahydropyrazolo-pyrazinyl-dihydroimidazolone or tetrahydropyrazolo-pyridinyl-dihydroimidazolone compounds and methods of using same | 20200720 |
JP-2019099571-A | Pharmaceutical composition containing pyrazolopyridine derivative having GLP-1 receptor agonist activity | 20171129 |
AU-2017330733-A1 | Pyrazolopyridine derivative having GLP-1 receptor agonist effect | 20160926 |
AU-2017330733-B2 | Pyrazolopyridine derivative having GLP-1 receptor agonist effect | 20160926 |
CA-3038479-A1 | Pyrazolopyridine derivative having glp-1 receptor agonist effect | 20160926 |
EP-3517538-A1 | Pyrazolopyridine derivative having glp-1 receptor agonist effect | 20160926 |
JP-2019203015-A | Pyrazolopyridine derivatives having GLP-1 receptor agonist activity | 20160926 |
JP-6567778-B2 | Pyrazolopyridine derivatives having GLP-1 receptor agonist activity | 20160926 |
JP-WO2018056453-A1 | Pyrazolopyridine derivatives having GLP-1 receptor agonist activity | 20160926 |
KR-20190039591-A | Pyrazolopyridine derivatives having GLP-1 receptor agonist action | 20160926 |
Complexity: | 164 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 1 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 137.99867984 |
Formal Charge: | 0 |
Heavy Atom Count: | 8 |
Hydrogen Bond Acceptor Count: | 4 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 137.99867984 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 61Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | -0.1 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS